Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q1)Jun 30, 2025 | (FY)Mar 31, 2025 | (Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -3.60%9.38B | 0.10%39.14B | 0.48%9.73B | 0.31%39.1B | -1.06%9.35B | -1.12%10.22B | 1.06%9.86B | 2.46%9.68B | 5.99%38.98B | 5.33%9.45B |
| Cost of revenue | -3.37%6.11B | 1.84%26.52B | 3.93%6.32B | 12.03%26.04B | 15.99%6.61B | 12.71%6.83B | 6.33%6.51B | 13.55%6.08B | 8.80%23.24B | 7.00%5.7B |
| Gross profit | -4.00%3.27B | -3.38%12.62B | -5.37%3.4B | -17.01%13.06B | -27.03%2.73B | -20.71%3.39B | -7.83%3.34B | -12.10%3.6B | 2.10%15.74B | 2.91%3.74B |
| Operating expense | 12.05%2.32B | -0.94%8.81B | -9.90%2.07B | -2.32%8.89B | -5.66%2.05B | -4.96%2.28B | -1.30%2.27B | 2.73%2.29B | -1.90%9.11B | -5.73%2.17B |
| Operating profit | -28.82%951M | -8.59%3.81B | 2.61%1.34B | -37.17%4.17B | -56.59%682M | -40.82%1.11B | -19.14%1.07B | -29.92%1.3B | 8.15%6.64B | 17.85%1.57B |
| Net non-operating interest income (expenses) | -76.27%14M | -36.28%144M | 20.41%59M | 193.51%226M | 53.66%63M | 111.11%57M | 1,040.00%57M | 1,125.00%49M | 133.33%77M | 583.33%41M |
| Non-operating interest income | -35.38%42M | -14.06%214M | 18.18%65M | 134.91%249M | 41.67%68M | 85.29%63M | 384.62%63M | 400.00%55M | 171.79%106M | 336.36%48M |
| Non-operating interest expense | 366.67%28M | 204.35%70M | 0.00%6M | -20.69%23M | -28.57%5M | -14.29%6M | -25.00%6M | -14.29%6M | 383.33%29M | 40.00%7M |
| Net investment income | 700.00%8M | 395.24%104M | 101.49%1M | -57.14%21M | -15.38%-15M | -23.73%45M | 222.22%58M | -346.67%-67M | 2,350.00%49M | 18.75%-13M |
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | -7,300.00%-74M | 75.40%-46M | 98.75%-1M | -32.62%-187M | 74.44%-46M | -106.32%-6M | -7.84%-55M | -1,500.00%-80M | -56.67%-141M | -300.00%-180M |
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | 3,533.33%103M | -579.10%-910M | -3M | 71.06%-134M | 64.58%-164M | -10M | 40M | 0 | -734.25%-463M | -463M |
| Less:Other special charges | -3,533.33%-103M | 409.38%198M | --3M | -6,300.00%-64M | ---34M | --10M | ---- | ---- | 98.63%-1M | ---- |
| Less:Write off | ---- | 259.60%712M | ---- | -57.33%198M | ---- | ---- | ---- | ---- | --464M | ---- |
| Other non-operating income (expenses) | -83.33%2M | -773.68%-166M | -53.85%12M | -161.29%-19M | -900.00%-64M | 350.00%9M | -47.37%10M | 1,200.00%26M | -76.52%31M | 112.31%8M |
| Income before tax | -28.53%1B | -28.00%2.93B | 14.08%1.4B | -34.16%4.08B | -52.44%458M | -41.67%1.2B | -10.24%1.18B | -33.32%1.23B | -1.54%6.19B | -20.68%963M |
| Income tax | -31.90%269M | 10.22%1.41B | 13.83%395M | -32.67%1.28B | -27.15%263M | -44.35%330M | -14.93%342M | -36.68%347M | -2.41%1.9B | -34.12%361M |
| Net income | -27.24%732M | -45.58%1.52B | 14.19%1.01B | -34.82%2.79B | -67.66%195M | -40.54%874M | -8.17%843M | -31.92%881M | -1.13%4.29B | -9.46%603M |
| Net income continuous operations | -27.21%733M | -45.54%1.52B | 14.17%1.01B | -34.82%2.79B | -67.61%195M | -40.58%874M | -8.18%842M | -31.89%882M | -1.15%4.29B | -9.61%602M |
| Noncontrolling interests | 0 | 0 | 0 | 64.52%-11M | 0 | 57.14%-3M | 63.64%-4M | 55.56%-4M | 11.43%-31M | 63.64%-4M |
| Net income attributable to the company | -27.24%732M | -45.79%1.52B | 13.54%1.01B | -35.03%2.8B | -67.82%195M | -40.66%877M | -8.84%846M | -32.06%886M | -1.24%4.32B | -10.62%606M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | -27.24%732M | -45.79%1.52B | 13.54%1.01B | -35.03%2.8B | -67.82%195M | -40.66%877M | -8.84%846M | -32.06%886M | -1.24%4.32B | -10.62%606M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | -18.02%33.99 | -41.18%67.98 | 13.50%41.46 | -35.05%115.57 | -67.85%8.03 | -40.68%36.14 | -8.91%34.87 | -32.06%36.53 | 16.31%177.95 | -6.55%24.98 |
| Diluted earnings per share | -18.02%33.99 | -41.18%67.98 | 13.50%41.46 | -35.05%115.57 | -67.85%8.03 | -40.69%36.1289 | -8.85%34.87 | -32.06%36.53 | 16.31%177.95 | -6.55%24.98 |
| Dividend per share | 18.75%23.75 | 0.00%80 | 0.00%20 | 12.68%80 | 11.11%20 | 11.11%20 | 14.29%20 | 14.29%20 | 4.41%71 | 5.88%18 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |